» Authors » Riham Fliefel

Riham Fliefel

Explore the profile of Riham Fliefel including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 20
Citations 232
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Obermeier K, Dewenter I, Malenova Y, Fliefel R, Kaeppler G, Otto S
Sci Rep . 2024 Apr; 14(1):7914. PMID: 38575664
Medication-related osteonecrosis of the jaw (MRONJ) is a serious adverse reaction associated with antiresorptive drugs such as bisphosphonates and denosumab. When dealing with advanced and/or multiple MRONJ lesions undergoing surgical...
2.
Dewenter I, Kumbrink J, Poxleitner P, Smolka W, Liokatis P, Fliefel R, et al.
Oral Oncol . 2023 Nov; 147:106573. PMID: 37951115
Oral squamous cell carcinoma (OSCC) is the most common cancer in the oral cavity accounting for 90 % of oral cancer with a global incidence of 350.000 new cases per...
3.
Aljohani S, Fliefel R, Brunner T, Chronopoulos A, Binmadi N, Otto S
J Int Med Res . 2022 Jun; 50(6):3000605221104186. PMID: 35698727
Objective: Osteoradionecrosis of the jaw (ORNJ) is one of the most severe head and neck complications in patients treated with radiotherapy. The goal of treatment is to suppress ORNJ progression....
4.
Ghanem M, Heikal L, Abdel Fattah H, El Ashwah A, Fliefel R
J Clin Med . 2022 Jun; 11(11). PMID: 35683447
Background: The healing of an extraction socket leads to alveolar ridge resorption that can hinder future implant placement and further rehabilitation with special concerns in diabetes mellitus. Coenzyme Q10 (CoQ10)...
5.
Otto S, Schnoedt E, Troeltzsch M, Kaeppler G, Aljohani S, Liebermann A, et al.
J Oral Implantol . 2022 Apr; 49(1):39-45. PMID: 35446931
Medication-related osteonecrosis of the jaw (MRONJ) is a serious concern for dentists as well as maxillofacial surgeons. Therefore, the safety of dental implant placement in patient receiving antiresorptive drugs (ARDs)...
6.
Haidari S, Troltzsch M, Fliefel R, Jungbluth A, Otto S, Fegg F, et al.
J Oral Pathol Med . 2022 Apr; 51(5):421-428. PMID: 35430758
Background: The objective was to assess the expression patterns of the cancer testis antigen PRAME, NY-ESO1, and SSX2 in oral squamous cell carcinoma (OSSC) and to correlate the expression with...
7.
Fliefel R, Otto S
Oral Surg Oral Med Oral Pathol Oral Radiol . 2021 Nov; 133(1):120. PMID: 34753698
No abstract available.
8.
Otto S, Aljohani S, Fliefel R, Ecke S, Ristow O, Burian E, et al.
Medicina (Kaunas) . 2021 Jun; 57(5). PMID: 34065104
Medication-related osteonecrosis of the jaw (MRONJ) has become a well-known side effect of antiresorptive, and antiangiogenic drugs commonly used in cancer management. Despite a considerable amount of literature addressing MRONJ,...
9.
El Gezawi M, Wolfle U, Haridy R, Fliefel R, Kaisarly D
ACS Biomater Sci Eng . 2021 Jan; 5(10):4899-4919. PMID: 33455239
Currently, the principal strategy for the treatment of carious defects involves cavity preparations followed by the restoration of natural tooth structure with a synthetic material of inferior biomechanical and esthetic...
10.
Otto S, Schnodt E, Haidari S, Brunner T, Aljohani S, Mosleh M, et al.
Oral Surg Oral Med Oral Pathol Oral Radiol . 2020 Dec; 131(5):519-526. PMID: 33309263
Objective: Medication-related osteonecrosis of the jaw (MRONJ) has become a serious concern for patients under antiresorptive treatment, especially in the oncological setting. Different approaches have been described in the management...